NDC 60505-6128 – Irinotecan Hydrochloride
Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Intravenous
Product NDC60505-6128
Product details
- Brand name
- Irinotecan Hydrochloride
- Generic name
- Irinotecan Hydrochloride
- Labeler
- Apotex Corp.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA203380
- Marketed since
- November 30, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Topoisomerase Inhibitor
Active ingredients
- Irinotecan Hydrochloride 20 mg/mL
Uses, dosage, side effects and warnings for Irinotecan Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 60505-6128-0 | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-0) / 2 mL in 1 VIAL, SINGLE-USE | Nov 30, 2017 |
| 60505-6128-1 | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-1) / 5 mL in 1 VIAL, SINGLE-USE | Nov 30, 2017 |
Other Irinotecan Hydrochloride products
- 45963-614 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Actavis Pharma, Inc.
- 60505-6272 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Apotex Corp.
- 55150-352 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-353 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-354 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 55150-355 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Eugia US LLC
- 63323-193 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 61703-349 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Hospira, Inc.
- 67184-0513 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0512 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 67184-0511 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Qilu Pharmaceutical Co., Ltd.
- 25021-230 Irinotecan Hydrochloride 20 mg/mL · Injection, Solution · Sagent Pharmaceuticals